NXT USA has announced that the patented ingredient TamaFlex has been officially registered as a Food with Functional Claim (FFC) in Japan by the Consumer Affairs Agency (CAA).
NXT USA (Edison, NJ) has announced that the patented ingredient TamaFlex has been officially registered as a Food with Functional Claim (FFC) in Japan by the Consumer Affairs Agency (CAA). This registration was achieved in collaboration with Octroll, which is a key player in Japan’s functional health food market.
"We are honored to have TamaFlex recognized as an FFC ingredient in Japan,” said Hiroyuki Tanaka, CEO of Octroll Inc., in a press release. “This approval places TamaFlex in an exclusive category of natural ingredients, scientifically validated for specific health benefits. Japanese consumers can trust in its proven efficacy, knowing it meets the rigorous standards set by the CAA. Our three double-blind, placebo-controlled clinical studies have provided the scientific foundation for this recognition, demonstrating the product’s reliability."
The FFC system, explains NXT in a press release, ensures that products marketed under that label are safe, effective, and meet stringent quality standards. In order to quality, NXT and Octroll had to provide clinical data and systematic reviews demonstrating the ingredient’s safety and effectiveness. The three human clinical studies mentioned by Tanaka involved more than 300 participants and showed significant improvements in joint health at 250 mg per day.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.